Dr. David Holtzman, a member of Cure Alzheimer’s Fund Research Consortium, received the prestigious MetLife Foundation Award for Medical Research in Alzheimer’s Disease.
The MetLife Foundation has supported Alzheimer’s disease research and outreach activities for more than 20 years. Dr. Holtzman was honored for his pioneering work in molecular biology examining the early stages of Alzheimer’s disease.
In addition to his role at Cure Alzheimer’s Fund, Dr. Holtzman is the Andrew B. and Gretchen P. Jones Professor of Neurology and Molecular Biology & Pharmacology at Washington University School of Medicine in St. Louis, and Head of the Department of Neurology. He is associate director of the Alzheimer’s Disease Research Center at Washington University. Dr. Holtzman has also been honored with the Potamkin Prize from the American Academy of Neurology, the MERIT award from the National Institute on Aging, and the Zenith Award from the Alzheimer’s Association.Currently Cure Alzheimer’s Fund is supporting his research project titled “The Role of Synaptic Activity and Neurotransmitter Modulation in the Dynamic Regulation of Interstitial Fluid Abeta and Oligomer Formation”.